๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Autologous bone marrow transplantation in acute leukemia

โœ Scribed by A.R Zander; D.S Verma; G Spitzer; S Culbert; L Peters; K McCredie; K.A Dicke

Publisher
Elsevier Science
Year
1979
Tongue
English
Weight
267 KB
Volume
5
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab with interleukin-2 after autol
Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission
โœ Ozsahin, Hulya ;Fluss, Jo๏ฟฝl ;Mc Lin, Valerie ;Wacker, Pierre ;Miralbell, Raymond ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 35 KB

To the Editor: Relapse is still a problem for leukemias, particularly in the autologous bone marrow transplantation (ABMT) setting. Moreover, the CD20 positive phenotype, deยฎned as >20% expression, may be associated with a worse outcome [1]. Therefore, our experience with such a patient in whom we a

Double autologous bone marrow transplant
Double autologous bone marrow transplantation for acute myelogenous leukemia in a patient treated for Hodgkin's disease
โœ Russell, J. A. ;Jones, A. R. ;Houwen, B. ;Poon, M.-C. ;Ruether, B. A. ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 373 KB

A 30-year-old man developed acute myelogenous leukemia nearly 3 years after. treatment of Hodgkin's disease with radiation and three chemotherapy combinations. Remission was induced with one cycle of highdose Ara-C therapy. Three cycles of consolidation chemotherapy were given. The patient then had